Hi ,

Is dependability the primary factor you consider in a research partner? Did you know that Sanofi has trusted Sanguine to prospectively procure biospecimens for over 50 studies? Studies have ranged from single-draw, single-indication collections to a prospective biobank covering 4 autoimmune diseases and matched controls from 225 patients. Clearly, we make a good team in implementing critical studies in humans.

Regardless of your pipeline stage (preclinical, translational, clinical) or disease indication you can customize the study size and scope to accelerate results with a prospective in-home collection or clinical site coordination, including:

  • Specific inclusion/exclusion criteria
  • Fresh collection, same-day delivery, and fast turnaround time
  • Supplement blood draws with diverse samples, such as skin tapes and stool
  • Preanalytical lab services (PBMC isolation, HLA typing, etc.)

If you are contemplating a new study or would like to learn more for a future study, please respond directly to this email or schedule a time on my calendar.

Warm Regards,

Alison Jones
Research Consultant
Sanguine Bio | Massachusetts

Schedule a Meeting
| www.sanguinebio.com